Job F M van Boven
Job F M van Boven is an expert in Pulmonology at University Medical Center Groningen (Netherlands). As of October 2026, ScienceLeadR ranks Job F M van Boven in the top 1% of experts worldwide for Asthma, Hypersensitivity and Lung Diseases, Obstructive. Job F M van Boven has authored 243 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 3 of them ongoing. SLR score: 943 (community average: 125). How the SLR is computed.
LeadR Profile
Pulmonology
Subspecialties: Pharmacy - Immunology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2026
Number : 243
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Inhaler Adherence and Inhalation Technique Assessed by a Smart Spacer in Patients with Severe Asthma on Biologics NCT06360393 — inhalation, respiratory aspiration, medication adherence, therapeutics, asthma, biological therapy | N/A | Recruiting | 2024 |
| Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels NCT05525338 — cells, genes, lung, pharmaceutical preparations, lymphoma, neoplasms, drug monitoring, carcinoma, non-small-cell lung, lung neoplasms, therapeutics, anaplastic lymphoma kinase, mutation, carcinoma | Phase 4 | Recruiting | 2022 |
| Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease NCT05495698 — chronic disease, lung, multiple chronic conditions, pulmonary disease, chronic obstructive, medication adherence, therapeutics, lung diseases, lung diseases, obstructive | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map